Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 20 (Search time: 0.01 seconds).
Item hits:
Issue DateTitleAuthor(s)
2013Epigenetics in Friedreich's ataxia: Challenges and opportunities for therapySandi, C; Al-Mahdawi, S; Pook, MA
2012Pms2 suppresses large expansions of the (GAA·TTC)n sequence in neuronal tissuesBourn, RL; De Biase, I; Pinto, RM; Sandi, C; Al-Mahdawi, S; Pook, MA; Bidichandani, S
2012Novel frataxin isoforms may contribute to the pathological mechanism of friedreich ataxiaXia, H; Cao, Y; Dai, X; Marelja, Z; Zhou, D; Mo, R; Al-Mahdawi, S; Pook, MA; Leimkühler, S; Rouault, TA; Li, K
2013Pharmacological screening using an FXN-EGFP cellular genomic reporter assay for the therapy of Friedreich ataxiaLi, L; Voullaire, L; Sandi, C; Pook, MA; Ioannou, PA; Delatycki, MB; Sarsero, JP
2013Friedreich ataxia patient tissues exhibit increased 5-hydroxymethylcytosine modification and decreased CTCF binding at the FXN locusAl-Mahdawi, S; Sandi, C; Mouro Pinto, R; Pook, MA
2015A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia.Anjomani Virmouni, S; Ezzatizadeh, V; Sandi, C; Sandi, M; Al-Mahdawi, S; Chutake, Y; Pook, MA
2015FXN promoter silencing in the humanized mouse model of Friedreich AtaxiaChutake, YK; Costello, WN; Lam, CC; Parikh, AC; Hughes, TT; Michalopulos, MG; Pook, MA; Bidichandani, SI
2014The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseasesAl-Mahdawi, S; Virmouni, SA; Pook, MA
2014MutLα heterodimers modify the molecular phenotype of Friedreich ataxiaEzzatizadeh, V; Sandi, C; Sandi, M; Anjomani-Virmouni, S; Al-Mahdawi, S; Pook, MA
2014Epigenetic-based therapies for Friedreich ataxiaSandi, C; Sandi, M; Virmouni, SA; Al-Mahdawi, S; Pook, MA